• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染期间的肠道损伤、炎症及微生物群改变

Intestinal Damage, Inflammation and Microbiota Alteration during COVID-19 Infection.

作者信息

Saviano Angela, Brigida Mattia, Petruzziello Carmine, Zanza Christian, Candelli Marcello, Morabito Loprete Maria Rita, Saleem Faiz, Ojetti Veronica

机构信息

Emergency Department, Fondazione Policlinico Universitario A. Gemelli, 00168 Roma, Italy.

Department of Gastroenterology, Policlinico Tor Vergata, 00133 Roma, Italy.

出版信息

Biomedicines. 2023 Mar 27;11(4):1014. doi: 10.3390/biomedicines11041014.

DOI:10.3390/biomedicines11041014
PMID:37189632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10135602/
Abstract

BACKGROUND

The virus SARS-CoV-2 is responsible for respiratory disorders due to the fact that it mainly infects the respiratory tract using the Angiotensin-converting enzyme 2 (ACE2) receptors. ACE2 receptors are also highly expressed on intestinal cells, representing an important site of entry for the virus in the gut. Literature studies underlined that the virus infects and replicates in the gut epithelial cells, causing gastrointestinal symptoms such as diarrhea, abdominal pain, nausea/vomiting and anorexia. Moreover, the SARS-CoV-2 virus settles into the bloodstream, hyperactivating the platelets and cytokine storms and causing gut-blood barrier damage with an alteration of the gut microbiota, intestinal cell injury, intestinal vessel thrombosis leading to malabsorption, malnutrition, an increasing disease severity and mortality with short and long-period sequelae.

CONCLUSION

This review summarizes the data on how SARS-CoV-2 effects on the gastrointestinal systems, including the mechanisms of inflammation, relationship with the gut microbiota, endoscopic patterns, and the role of fecal calprotectin, confirming the importance of the digestive system in clinical practice for the diagnosis and follow-up of SARS-CoV-2 infection.

摘要

背景

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发呼吸系统疾病,因为它主要利用血管紧张素转换酶2(ACE2)受体感染呼吸道。ACE2受体在肠道细胞中也高度表达,是病毒进入肠道的重要部位。文献研究强调,该病毒在肠道上皮细胞中感染并复制,导致腹泻、腹痛、恶心/呕吐和厌食等胃肠道症状。此外,SARS-CoV-2病毒进入血液,使血小板过度活化并引发细胞因子风暴,导致肠-血屏障受损,同时伴有肠道微生物群改变、肠道细胞损伤、肠道血管血栓形成,进而导致吸收不良、营养不良,疾病严重程度和死亡率增加,并伴有短期和长期后遗症。

结论

本综述总结了SARS-CoV-2对胃肠道系统影响的数据,包括炎症机制、与肠道微生物群的关系、内镜检查模式以及粪便钙卫蛋白的作用,证实了消化系统在SARS-CoV-2感染的临床诊断和随访中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e583/10135602/c2c7b09269bf/biomedicines-11-01014-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e583/10135602/6c1319b2164e/biomedicines-11-01014-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e583/10135602/c2c7b09269bf/biomedicines-11-01014-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e583/10135602/6c1319b2164e/biomedicines-11-01014-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e583/10135602/c2c7b09269bf/biomedicines-11-01014-g002.jpg

相似文献

1
Intestinal Damage, Inflammation and Microbiota Alteration during COVID-19 Infection.新冠病毒感染期间的肠道损伤、炎症及微生物群改变
Biomedicines. 2023 Mar 27;11(4):1014. doi: 10.3390/biomedicines11041014.
2
Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.COVID-19 患者胃肠道症状的病理生理机制。
World J Gastroenterol. 2021 May 21;27(19):2341-2352. doi: 10.3748/wjg.v27.i19.2341.
3
Intestinal Damage in COVID-19: SARS-CoV-2 Infection and Intestinal Thrombosis.新型冠状病毒肺炎中的肠道损伤:严重急性呼吸综合征冠状病毒2感染与肠道血栓形成
Front Microbiol. 2022 Mar 22;13:860931. doi: 10.3389/fmicb.2022.860931. eCollection 2022.
4
Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions.新冠康复期胃肠道的症状学与微生物学
JGH Open. 2022 Aug 25;6(10):667-76. doi: 10.1002/jgh3.12811.
5
Herbal Medicine, Gut Microbiota, and COVID-19.草药医学、肠道微生物群与2019冠状病毒病
Front Pharmacol. 2021 Jul 7;12:646560. doi: 10.3389/fphar.2021.646560. eCollection 2021.
6
Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19.新型冠状病毒肺炎的胃肠道症状、病理生理学及治疗
Genes Dis. 2021 Jul;8(4):385-400. doi: 10.1016/j.gendis.2020.08.013. Epub 2020 Sep 5.
7
Implications of SARS-CoV-2 infection for neurogastroenterology.严重急性呼吸综合征冠状病毒 2 感染对神经胃肠病学的影响。
Neurogastroenterol Motil. 2021 Mar;33(3):e14104. doi: 10.1111/nmo.14104. Epub 2021 Feb 16.
8
Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges.2019冠状病毒病对肠道的影响:临床表现、病理学、管理及挑战综述
Acta Med Indones. 2021 Jan;53(1):96-104.
9
Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.感染 SARS-CoV-2 后肠道微生物组的改变与仓鼠疾病严重程度相关。
Gut Microbes. 2022 Jan-Dec;14(1):2018900. doi: 10.1080/19490976.2021.2018900.
10
ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.ACE2 失衡是与年龄相关合并症的 COVID-19 患者预后不良的关键因素 - 肠道微生物失调的作用。
Ageing Res Rev. 2020 Sep;62:101123. doi: 10.1016/j.arr.2020.101123. Epub 2020 Jul 16.

引用本文的文献

1
Autophagy-enhancing strategies to promote intestinal viral resistance and mucosal barrier function in SARS-CoV-2 infection.增强自噬的策略以促进肠道对SARS-CoV-2感染的病毒抵抗力和黏膜屏障功能。
Autophagy Rep. 2025 Jun 10;4(1):2514232. doi: 10.1080/27694127.2025.2514232. eCollection 2025.
2
New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx.在布朗克斯区市中心人群中,新冠病毒感染3.5年后新冠患者出现的新发胃肠疾病
Sci Rep. 2024 Dec 30;14(1):31850. doi: 10.1038/s41598-024-83232-7.
3
Surgical aspects of pediatric abdominal pain in the era of COVID-19: clinical consideration and outcomes.

本文引用的文献

1
Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.2019 年冠状病毒病中肠道微生物组的改变及其治疗潜力。
World J Gastroenterol. 2022 Dec 21;28(47):6689-6701. doi: 10.3748/wjg.v28.i47.6689.
2
Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells.细胞因子风暴和细菌感染在 COVID-19 患者中的关键作用:间充质干细胞的治疗潜力。
Inflammopharmacology. 2023 Feb;31(1):171-206. doi: 10.1007/s10787-022-01132-6. Epub 2023 Jan 4.
3
Gastrointestinal microbiota: A predictor of COVID-19 severity?
COVID-19时代小儿腹痛的外科问题:临床考量与结果
Front Pediatr. 2024 Sep 30;12:1400638. doi: 10.3389/fped.2024.1400638. eCollection 2024.
4
Alterations in microbiota of patients with COVID-19: implications for therapeutic interventions.新型冠状病毒肺炎患者微生物群的改变:对治疗干预的启示
MedComm (2020). 2024 Mar 15;5(4):e513. doi: 10.1002/mco2.513. eCollection 2024 Apr.
5
Elevated level of circulating calprotectin correlates with severity and high mortality in patients with COVID-19.循环钙卫蛋白水平升高与 COVID-19 患者的严重程度和高死亡率相关。
Immun Inflamm Dis. 2024 Mar;12(3):e1212. doi: 10.1002/iid3.1212.
6
Small Bowel Diverticulosis and COVID-19: Awareness Is the Key: A Case Series and Review of the Literature.小肠憩室病和 COVID-19:认识是关键:病例系列和文献复习。
Medicina (Kaunas). 2024 Jan 29;60(2):229. doi: 10.3390/medicina60020229.
7
Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization.定义新冠病毒奥密克戎亚变体BA.2.12.1和BA.4/5的突变对刺突蛋白功能和中和作用的影响
iScience. 2023 Oct 27;26(11):108299. doi: 10.1016/j.isci.2023.108299. eCollection 2023 Nov 17.
肠道微生物群:预测 COVID-19 严重程度的指标?
World J Gastroenterol. 2022 Dec 7;28(45):6328-6344. doi: 10.3748/wjg.v28.i45.6328.
4
Effect of COVID-19 on gastrointestinal endoscopy practice: a systematic review.COVID-19 对胃肠内镜实践的影响:系统评价。
Ann Med. 2022 Dec;54(1):2875-2884. doi: 10.1080/07853890.2022.2133163.
5
Induction of Hypoxic Response in Caco-2 Cells Promote the Expression of Genes Involved in SARS-CoV-2 Endocytosis and Transcytosis.诱导 Caco-2 细胞产生低氧反应可促进与 SARS-CoV-2 内吞和转胞运输相关基因的表达。
Dokl Biochem Biophys. 2022 Oct;506(1):206-209. doi: 10.1134/S1607672922050118. Epub 2022 Oct 27.
6
Gut microbiota: A new insight into lung diseases.肠道微生物群:肺部疾病的新视角。
Biomed Pharmacother. 2022 Nov;155:113810. doi: 10.1016/j.biopha.2022.113810. Epub 2022 Oct 8.
7
Probiotics: A gut response to the COVID-19 pandemic but what does the evidence show?益生菌:对 COVID-19 大流行的肠道反应,但证据表明了什么?
Clin Nutr ESPEN. 2022 Oct;51:17-27. doi: 10.1016/j.clnesp.2022.08.023. Epub 2022 Aug 22.
8
Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis.COVID-19 患者的血浆微生物组:肠道屏障缺陷和菌群失调的指标。
Int J Mol Sci. 2022 Aug 15;23(16):9141. doi: 10.3390/ijms23169141.
9
COVID-19: gastrointestinal and hepatobiliary manifestations.新型冠状病毒肺炎:胃肠道和肝胆系统表现。
Hum Pathol. 2023 Feb;132:39-55. doi: 10.1016/j.humpath.2022.07.006. Epub 2022 Jul 16.
10
COVID-19 Pneumonia and Gut Inflammation: The Role of a Mix of Three Probiotic Strains in Reducing Inflammatory Markers and Need for Oxygen Support.新冠肺炎与肠道炎症:三种益生菌菌株组合在降低炎症标志物及减少氧气支持需求方面的作用
J Clin Med. 2022 Jun 28;11(13):3758. doi: 10.3390/jcm11133758.